BL PharmTech (065170.KQ) Stock Price

BL PharmTech Price

CLOSED
1,997.00
​
Market closed

Revenue at BL PharmTech has contracted by 5.6% per year over the past 19 years to 6.51 B KRW. Earnings per share have declined at 14.3% per year over the last 12 years. BL PharmTech's net margin stands at -257.9%, down from -23.9% several years earlier.

BL PharmTech stock price

Access this data via the Eulerpool API

BL PharmTech business model & stock analysis

BL Pharmtech Corp. engages in health food industry. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2002-11-19. The firm operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Frequently asked questions about BL PharmTech

Converted at the current exchange rate, the BL PharmTech share trades at 1.33 EUR (1,997.00 KRW).

The revenue cannot currently be calculated for BL PharmTech.

The profit cannot currently be calculated for BL PharmTech.

The P/E ratio cannot be calculated for BL PharmTech at the moment.

The P/S cannot be calculated for BL PharmTech currently.

The Eulerpool Quality Score for BL PharmTech is 3/10.

The ISIN of BL PharmTech is KR7065170003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of BL PharmTech is 065170.KQ. The ticker symbol is used to trade BL PharmTech shares on the stock exchange.

Fair ValueTerminal
1,897.15 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 19, 2002
ISIN
KR7065170003
Cusip
Y6419G109
Market capitalization
53.30 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
2,303.23
P/B Ratio
6.75
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-212.49 %
Last updated Oct 15, 2026, 4:03 AM

BL PharmTech Peer Group

BL PharmTech FIGI

065170:KS · BBG000PLBK62065170:KQ · BBG000PLBL33

All fundamentals and in-depth analysis of BL PharmTech

Our stock analysis for BL PharmTech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BL PharmTech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.